{"id":"https://openalex.org/W4366083274","doi":"https://doi.org/10.1007/s13300-023-01399-0","title":"Gaps Remain for Achieving HbA1c Targets for People with Type 1 or Type 2 Diabetes Using Insulin: Results from NHANES 2009\u20132020","display_name":"Gaps Remain for Achieving HbA1c Targets for People with Type 1 or Type 2 Diabetes Using Insulin: Results from NHANES 2009\u20132020","publication_year":2023,"publication_date":"2023-04-17","ids":{"openalex":"https://openalex.org/W4366083274","doi":"https://doi.org/10.1007/s13300-023-01399-0","pmid":"https://pubmed.ncbi.nlm.nih.gov/37067668","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10108820"},"language":"en","primary_location":{"id":"doi:10.1007/s13300-023-01399-0","doi":"https://doi.org/10.1007/s13300-023-01399-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-023-01399-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-023-01399-0.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6953","issn":["1869-6953","1869-6961"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s13300-023-01399-0.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053784299","display_name":"Emily R. Hankosky","orcid":"https://orcid.org/0000-0001-9934-584X","observed_orcids":["https://orcid.org/0000-0001-9934-584X"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Emily R. Hankosky","raw_affiliation_strings":["Value, Evidence and Outcomes (VEO)-Diabetes, Eli Lilly and Company, Indianapolis, IN, USA. emily.hankosky@lilly.com","Value, Evidence and Outcomes (VEO)\u2014Diabetes, Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Value, Evidence and Outcomes (VEO)-Diabetes, Eli Lilly and Company, Indianapolis, IN, USA. emily.hankosky@lilly.com","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Value, Evidence and Outcomes (VEO)\u2014Diabetes, Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087813058","display_name":"David Schapiro","orcid":"https://orcid.org/0000-0002-3083-3615","observed_orcids":["https://orcid.org/0000-0002-3083-3615"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Schapiro","raw_affiliation_strings":["Value, Evidence and Outcomes (VEO)-Diabetes, Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Value, Evidence and Outcomes (VEO)-Diabetes, Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024752462","display_name":"Karli B. Gunn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karli B. Gunn","raw_affiliation_strings":["Value, Evidence and Outcomes (VEO)-Diabetes, Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Value, Evidence and Outcomes (VEO)-Diabetes, Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073233027","display_name":"Elizabeth B. Lubelczyk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth B. Lubelczyk","raw_affiliation_strings":["Value, Evidence and Outcomes (VEO)-Diabetes, Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Value, Evidence and Outcomes (VEO)-Diabetes, Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056666152","display_name":"Jessica Mitroi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Mitroi","raw_affiliation_strings":["Value, Evidence and Outcomes (VEO)-Diabetes, Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Value, Evidence and Outcomes (VEO)-Diabetes, Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015873957","display_name":"David R. Nelson","orcid":"https://orcid.org/0000-0002-3240-0725","observed_orcids":["https://orcid.org/0000-0002-3240-0725"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David R. Nelson","raw_affiliation_strings":["Value, Evidence and Outcomes (VEO)-Diabetes, Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Value, Evidence and Outcomes (VEO)-Diabetes, Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5053784299"],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":{"value":6850,"currency":"USD","value_usd":6850},"apc_paid":{"value":6850,"currency":"USD","value_usd":6850},"fwci":11.5892,"has_fulltext":true,"cited_by_count":57,"citation_normalized_percentile":{"value":0.99089404,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"14","issue":"6","first_page":"967","last_page":"975"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.01679999940097332,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10793","display_name":"Diabetes Management and Education","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8859999775886536},{"id":"https://openalex.org/keywords/hba1c-targets","display_name":"HbA1c targets","score":0.9359999895095825},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9470000267028809},{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.8690000176429749},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/insulin-therapy","display_name":"insulin therapy","score":0.9589999914169312},{"id":"https://openalex.org/keywords/basal-insulin","display_name":"basal insulin","score":0.6959999799728394},{"id":"https://openalex.org/keywords/mealtime-insulin","display_name":"mealtime insulin","score":0.9769999980926514},{"id":"https://openalex.org/keywords/individualized-glycemic-targets","display_name":"individualized glycemic targets","score":0.7059999704360962},{"id":"https://openalex.org/keywords/nhanes","display_name":"NHANES","score":0.7110000252723694}],"concepts":[{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.8627415299415588},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7972546815872192},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.568057119846344},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4374791979789734},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.296979695558548},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2719263732433319}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1007/s13300-023-01399-0","doi":"https://doi.org/10.1007/s13300-023-01399-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-023-01399-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-023-01399-0.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6953","issn":["1869-6953","1869-6961"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10108820","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10108820","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10108820/pdf/13300_2023_Article_1399.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Ther","raw_type":"Text"},{"id":"pmid:37067668","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37067668","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes therapy : research, treatment and education of diabetes and related disorders","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s13300-023-01399-0","doi":"https://doi.org/10.1007/s13300-023-01399-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-023-01399-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-023-01399-0.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6953","issn":["1869-6953","1869-6961"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320332162","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4366083274.pdf","grobid_xml":"https://content.openalex.org/works/W4366083274.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W2007221722","https://openalex.org/W2119105795","https://openalex.org/W2122898959","https://openalex.org/W2205628024","https://openalex.org/W2402991504","https://openalex.org/W2517165909","https://openalex.org/W2583717592","https://openalex.org/W2784184843","https://openalex.org/W2809046998","https://openalex.org/W2886361135","https://openalex.org/W2909166675","https://openalex.org/W2914447281","https://openalex.org/W2999306521","https://openalex.org/W3003592023","https://openalex.org/W3006043206","https://openalex.org/W3031122959","https://openalex.org/W3096909987","https://openalex.org/W3158321451","https://openalex.org/W3213842174","https://openalex.org/W4200358162","https://openalex.org/W4212810717","https://openalex.org/W4213092833","https://openalex.org/W4281701510"],"related_works":["https://openalex.org/W4281701510","https://openalex.org/W2653457112","https://openalex.org/W3191039731","https://openalex.org/W2021922953","https://openalex.org/W4391260127","https://openalex.org/W2887705980","https://openalex.org/W3176256474","https://openalex.org/W2807579999","https://openalex.org/W4393162693","https://openalex.org/W2406090673"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Glycated":[1],"hemoglobin":[2],"A1c":[3],"(HbA1c)":[4],"is":[5,19],"an":[6,172],"important":[7],"measure":[8],"to":[9,40,236],"assess":[10],"glycemic":[11,226,239],"control":[12],"and":[13,53,68,93,119,133,156,160,202,208],"predict":[14],"diabetes":[15,29,51,82,87,96],"complications.":[16],"However,":[17],"there":[18],"limited":[20],"information":[21],"on":[22],"trends":[23,42],"in":[24,43,105,153,165,177,186,241],"HbA1c":[25,44,106,123,143,183,197],"among":[26,45],"people":[27,152,164,181],"with":[28],"(PwDs)":[30],"who":[31,47],"use":[32,48],"insulin.":[33],"The":[34,137,191],"aim":[35],"of":[36,142,144,151,163,180,193,223],"this":[37],"study":[38,215,229],"was":[39,60,147,175,199],"describe":[41],"PwDs":[46,74,194,224],"insulin":[49,54,91,101],"by":[50,149,161],"type":[52,80,85,94],"regimen.":[55],"METHODS:":[56],"A":[57],"retrospective":[58],"analysis":[59,113],"conducted":[61],"using":[62,89,99,111,216],"data":[63,218],"from":[64],"the":[65,154,166,178,187,205,231],"National":[66],"Health":[67],"Nutrition":[69],"Examination":[70],"Survey":[71],"(NHANES,":[72],"2009-2020).":[73],"were":[75,109,128],"classified":[76],"into":[77],"three":[78],"cohorts:":[79],"1":[81],"mellitus":[83,88,97],"(T1DM),":[84,130],"2":[86,95],"mealtime":[90],"(T2DM-MTI),":[92,132],"(T2DM)":[98],"basal-only":[100,168,189,210],"(T2DM":[102,135],"basal-only).":[103,136],"Trends":[104],"over":[107,126],"time":[108],"assessed":[110],"regression":[112],"after":[114],"adjusting":[115],"for":[116,204,233],"age,":[117],"gender,":[118],"race/ethnicity.":[120],"RESULTS:":[121],"Mean":[122],"values":[124],"aggregated":[125],"2009-2020":[127],"8.0%":[129],"8.6%":[131,134],"American":[138],"Diabetes":[139],"Association-recommended":[140],"target":[141],"<":[145,184],"7%":[146,185],"achieved":[148],"25.2%":[150],"T1DM":[155],"T2DM-MTI":[157],"groups":[158],"each":[159],"12.3%":[162],"T2DM":[167,188,209],"group.":[169,190],"Over":[170],"time,":[171],"upward":[173],"trend":[174],"observed":[176],"percentage":[179,192],"achieving":[182,195],"individualized":[196],"targets":[198,240],"27.0%,":[200],"12.4%,":[201],"16.1%":[203],"T1DM,":[206],"T2DM-MTI,":[207],"groups,":[211],"respectively.":[212],"CONCLUSIONS:":[213],"Our":[214],"NHANES":[217],"suggests":[219],"that":[220],"approximately":[221],"25%":[222],"achieve":[225],"targets.":[227],"This":[228],"highlights":[230],"need":[232],"improved":[234],"therapies":[235],"better":[237],"manage":[238],"PwDs.":[242]},"counts_by_year":[{"year":2026,"cited_by_count":25},{"year":2025,"cited_by_count":23},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2023-04-19T00:00:00"}